Understanding the financial implications of the upcoming falsified medicines regulations

European Pharmaceutical Review – VOLUME 21 ISSUE 3 2016

Vote to level up the European Health Union in upcoming… 25 March 2024 The upcoming European elections will have a significant impact on…
Biosimilars Market Review 2023 18 September 2023 The purpose of this Market Review is to provide a…
Arun Narayan, Chairman of the Value Added Medicines Sector… 8 September 2021 The interview of Arun Narayan, Chairman ofthe Value Added Medicines…
Common Statement: Supporting Statement for the Council… 14 June 2023 As trade associations representing off-patent medicines and Active Pharmaceutical Ingredients…